Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer to drop rice seed business in Latin America

Bayer CropScience is to cease commercialisation of rice seed in Latin America from next year in order to focus on other key crops. The company is to redirect investments towards cotton, soybeans, fruit and vegetables. It has an “innovative product pipeline” in seeds and biotechnology for those crops, providing “great opportunities”, in Latin America, the company says. “The opportunities for innovation in biotechnology are enormous, but demand large investments,” Bayer global rice manager Alex Merege notes. That has led the company to prioritise its offering towards those crops in Latin America, he adds. The company is to market its Arize rice seed until next year. It will also continue to offer “innovative” crop protection products for use on rice. Furthermore, rice business will maintain its status as a “strategic crop” for Bayer globally, with particular concentration on Asia, where the company is market leader for rice.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG021978

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel